StrategyGen is committed to improving the performance of government funded programs through quality improvement, provider program integrity, training and education, market research and technical assistance.
Whether it is helping government agencies with evidence-based implementation, consulting with business decision makers to pursue new opportunities, or collaborating with physicians and hospitals to optimize quality and payment reform models, StrategyGen has the trusted knowledge and analytical insight.
The StrategyGen team facilitates the optimization of quality improvement and payment reform models as well as support expanding access to healthcare. StrategyGen has a long history of successful engagements on behalf of our clients – measured by customers satisfied, contracts retained, and new services awarded.
Quality-Driven Cost Improvement Capabilities
StrategyGen works with hospitals, health systems, and other grantees to implement evidence-based best practices, targeting specific outcome measures. We support the development and testing of an accurate and reliable core set of measures of patient-centered care for consistent use across the United States.
StrategyGen's expert team develops work plans, identifies and recommends measures and metrics to monitor and drive quality improvements including detailed data collection and proposals. We convene technical expert panels to develop collaborative recommendations.
Reduced Hospital Acquired Infections
Significant Cost Reductions and Savings
Increased Patient and Provider Satisfaction
Integrated Continuum of Care
Targeted Measures and Metrics
Increased Quality of Care
Realized Competitive Advantage
Quality Assurance Programs and Analysis
Market Research and Data Analytics Capabilities
StrategyGen has a demonstrated track record of advancing quality improvements, including data-driven and quality-driven cost improvements, integrating statistical and healthcare data analytics
StrategyGen’s insider knowledge of the healthcare industry enables us to deliver the primary market research instruments that target the right market segments, asking and answering the right questions for our clients.
StrategyGen designs studies and conducts longitudinal program evaluations from an activity’s inception through various milestones to outcomes, impacts and cost-related analysis. We analyze and synthesize secondary data, literature reviews and meta analyses. Services also include legal and policy analyses, customer satisfaction survey design, and internal management and organizational studies. We can assist with the design and implementation of compliance Marketplace / Exchange eligibility appeals processes.
Improved Market Position and Profitability
Strengthened Competitive Advantage
Accurate Market Forecasting
Discovered Market Opportunities
Customized Strategy Fitting Your Needs
Identify and Eliminate Barriers
Primary and Secondary Data Analysis
Understand Your Market and Patients Needs
Systematic Approach to Solve Complex Problems
Flexible Strategic Plan for Healthcare Reform
Technical Assistance and Contact Tracing Capabilities
StrategyGen disseminates evidence based best clinical practices, COVID-19 Compliance, and virus contact tracing best practices to c-suite executives, healthcare providers, and public health officials including health systems, physicians, clinicians, and Federal grantees.
Our clinical and academic teams develop and implement customized training, education and certification programs on a range of subjects such as COVID Compliance, patient and family engagement, clinical guidelines, and reliable design. We use our clinical expertise and research experience to train and provide COVID-19 and virus contact tracing services.
StrategyGen's programs ensure that staff will have the competencies to necessary to perform their jobs, improve public health and support their professional development.
Development of Clinical/Administrative Leaders
Successful Training Programs
Increased Department Productivity
Continuing Education Programs
Coordinated Team Building
Optimized Potential Market Share
Increased Reimbursement Revenue
Improved Quality and Patient Safety
Expanded Eligible Services
Identified Strategic Investment Opportunities